75000 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Description of Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Summary of Significant Accounting Policies - Anti-dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Stockholders' Equity - Schedule of Warrants Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Stockholders' Equity - Schedule of Outstanding Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Stockholders' Equity - Schedule of Assumptions to Estimate Fair Value of Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Segments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Segments - Summary of Significant Expense and Asset Categories (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Proceeds from Sale of Property, Plant, and Equipment Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment, Total Entity Incorporation State Country Code Prefered Stock, Shares Issued Issuance of preferred shares Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Plan Name [Axis] Entity Current Reporting Status Proceeds from the exercise of warrants Proceeds from warrant exercises Operating expenses Operating expenses: Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Shares Authorized Common Stock, Shares Authorized Share-Based Payment Arrangement, Tranche Three [Member] Tranche Three [Member] Document Fiscal Period Focus Entity Shell Company Operating Costs Operating costs Cash and Cash Equivalent Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Simdax License Agreement [Member] Common Stock, Shares Issued Common Stock, Shares issued Statement [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average exercise price per share, Granted Statement [Line Items] Warrants to Purchase Common Stock [Member] Warrant [Member] Entity Filer Category [Liabilities and Equity] Total liabilities and stockholders' equity Payables and Accruals [Abstract] Accrued liabilites: Other Assets, Miscellaneous, Current Miscellaneous other current assets Subsequent Event [Line Items] Covertible Preferred Shares Outstanding [Member] Options to purchase common stock (stock incentive plans and inducement grants) March Two Thousand Twenty Five Private Placement Financing [Member] March two thousand twenty five private placement financing member. March 2025 Private Placement Financing [Member] Public offering sale of common stock, warrants and prefunded warrants, shares. Public Offering Sale of Common Stock, Warrants and Prefunded Warrants, Shares Public offering sale of common stock, warrants, and prefunded warrants, net of offering costs, shares Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Prepaid Expense, Current [Abstract] Prepaid assets: Vesting [Domain] Number of shares, Options Outstanding, Options granted Shares Options, Granted Stock options granted Gross Proceeds Form Warrant Gross proceeds form warrant Earnings Per Share, Basic Net loss per share, basic Earnings Per Share, Basic, Total Agent Fees Direct Offering Expenses Agent fees and direct offering expenses Number of options outstanding Shares Options, Ending Shares Options, Beginning [Liabilities, Current] Total current liabilities Adjustments to reconcile net loss to net cash used in operating activities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Stock options, exercise price per share Cash uninsured amount Stockholders' equity Entity Small Business Increase (Decrease) in Accrued Liabilities Accrued liabilities Increase (Decrease) in Accrued Liabilities, Total Accumulated deficit Preferred Stock DESCRIPTION OF BUSINESS Description of Business Weighted average remaining vesting period Amendment Flag Loss Contingencies [Line Items] Loss Per Share LIABILITIES AND STOCKHOLDERS' EQUITY Entity Address Postal Zip Code [Net Cash Provided by (Used in) Operating Activities] Net cash used in operating activities Net cash used in operating activities Common Stock Entity Address Address Line 1 Schedule of Assumptions to Estimate Fair Value of Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Warrants, Weighted Average Exercise Price, Canceled/Expired Supplemental Cash Flow Information [Abstract] Supplemental Disclosures: Chief Financial Officer [Member] Class of Warrant or Right [Axis] Document Type Entity Central Index Key [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Net change in cash and cash equivalents Canceled Canceled/Expired Warrants, Canceled/Expired Subsequent Event Type [Domain] Anti- Securities Dilutive Balance Sheet Related Disclosures [Abstract] Common Stock, Par Value Common Stock, Par Value Pre-funded warrants Gross proceeds from common stock warrants Share-Based Payment Arrangement, Tranche One [Member] Tranche one [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual life (years), Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of shares options outstanding, exercised Exercise of options, shares Shares Options, Exercised Other Prepaid Expense, Current Other prepaid expenses Accrued liabilities Current Fiscal Year End Date Document Quarterly Report Entity Address State Or Province Stock Issued During Period, Value, Conversion of Convertible Securities Exercise of warrants, amount Prefered Stock ,Shares Outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Common Stock, Capital Shares Reserved for Future Issuance Shares remained available for issuance Class of Warrant or Right [Domain] Cash From Warrant Exercise Held at Transfer Agent Current Cash from warrant exercise held at transfer agent current. Cash from warrant exercise held at transfer agent Exercise of options, amount Stock Issued During Period, Value, Stock Options Exercised Subsequent Events [Member] Summary of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Number of additional shares of common stock authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Antidilutive Securities [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Stock option awards, vesting rights percentage Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Principles of Consolidation Interest on debt instrument Series A Preferred stock, par value $0.0001, authorized 5,181,346 shares; issued and outstanding 210, as of March 31, 2026 and December 31, 2025 Preferred stock, undeisgnated, authorized 4,818,654 shares Series A Preferred stock, par value $0.0001, authorized 5,181,346 shares; issued and outstanding 210, as of March 31, 2026 and December 31, 2025 Minimum [Member] Minimum Current assets Other segment items. Other segment items [Abstract] Other segment items Stock Options Description Stock Options Description Segment Reporting [Abstract] Current liabilities Commitments and Contingencies Commitments and contingencies; see Note 4 Shareholders' Equity and Share-Based Payments [Text Block] Stockholders' Equity Warrant to purchase share of common stock. Warrant To Purchase share of Common Stock Warrant to purchase share of common stock Forecast [Member] Estimated Fair Value Of The Inducement Stock Option Award Granted Accrued CRO expenses Accrued Clinical Research Organizations Expenses Accrued clinical research organizations expenses. Net Loss Loss Contingencies [Table] Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares and prefunded warrants outstanding, basic Weighted Average Number of Shares Outstanding, Basic, Total Scenario [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value, options exercisable Segment Reporting, Expense Information Used by CODM, Description Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Subsequent Events [Text Block] Subsequent Events APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total [Stockholders' Equity Attributable to Parent] Balance, amount Balance, amount Total stockholders' equity Preferred Stock, Par Value Dividend Yield CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY Tranche Two [Member] Share-Based Payment Arrangement, Tranche Two [Member] Share Based Compensation Award Tranche Four [Member] Share based compensation award tranche four. Tranche Four [Member] Series A Preferred Stock [Member] Use Of Estimates Use of Estimates Exercise Of Pre Funded Warrants Amount Exercise of pre-funded warrants, amount Entity Address Address Line 2 Preferred Stock Undesignated Shares Authorized Preferred Stock, Undesignated Shares Authorized Preferred Stock, Undesignated Shares Authorized Accrued Liabilities Summary of Accrued Liabilities Other Assets, Current Other current assets Total other current assets Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Plan Name [Domain] President and chief executive officer. President and Chief Executive Officer [Member] Business Description and Basis of Presentation [Text Block] Description of Business [Class of Warrant or Right, Outstanding] Warrants outstanding ending Warrants Outstanding Ending Warrants Outstanding Beginning Warrants outstanding Related Party [Axis] Class of Warrant or Right [Table] Entity Address City Or Town Cash, FDIC Insured Amount Cash, FDIC insurance limit Lease Term Period Security Exchange Name Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Non-qualified stock options granted Antidilutive Securities, Name [Domain] Stockholders' Equity Note [Abstract] February two thousand twenty four. February Two Thousand Twenty Four [Member] February 2024 [Member] Cash and cash equivalents Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total Interest Paid, Excluding Capitalized Interest, Operating Activity Cash paid for interest Statistical Measurement [Domain] [Class of Warrant or Right, Exercise Price of Warrants or Rights] Exercise price of warrants Issuance of pre fund warrant shares, offering price per share Warrants, Weighted Average Exercise Price, Beginning Warrants, Weighted Average Exercise Price, Ending [Assets, Current] Total current assets Compensation Expense Non-refundable commercialization milestone payment Document Period End Date Title and Position [Axis] Proceeds from the exercise of warrants and pre-funded warrants Proceeds from The Exercise of Warrants and Pre-Funded Warrants Proceeds from the exercise of warrants and pre-funded warrants. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Shares Options, Exercisable CONDENSED CONSOLIDATED BALANCE SHEETS Restricted Stock Units (RSUs) [Member] Antidilutive Security, Excluded EPS Calculation [Table] Vesting [Axis] Class of Stock [Axis] First Inducement Stock Options First Inducement Stock Options Member [Liabilities] Total liabilities Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Stock options term Common stock shares Prepaid Expense and Other Assets, Current [Abstract] Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares and prefunded warrants outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Entity File Number Cover [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, minimum Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Scenario [Domain] Number of Operating Segments Number of operating segment Segment Reporting Disclosure [Text Block] Segments General and administrative General and Administrative Expense, Total fair value allocated Fair value allocated Subsequent Event [Table] Number of shares of common stock authorized for issuance Number Of Shares Of Common Stock Authorized For Issuance Number Of Shares Of Common Stock Authorized For Issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted average exercise price per share, Ending balance Weighted average exercise price per Share, Beginning balance Inducement Stock Options [Member] Inducement Stock Options Member Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Stock Issued During Period, Shares, Conversion of Convertible Securities Exercise of warrants, shares Exercise of warrant Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Stock options, vesting period Stock options term Sharebased compensation arrangement by sharebased payment award options nonvested weighted average options exercisable. Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Options Exercisable Weighted average exercise price per share, Options Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, minimum Common Stock, Shares Outstanding Common Stock, Shares Outstanding Document Transition Report [Operating Expenses] Total operating expenses Research and development Research and Development Expense, Total CONSOLIDATED STATEMENTS OF CASH FLOWS Balance, shares [Shares, Issued] Balance, shares Net loss Net loss Net loss Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, ending balance Aggregate intrinsic value, beginning balance Issued unregistered warrants to purchase shares of common stock. Issued Unregistered Warrants to Purchase Shares of Common Stock Issued unregistered warrants to purchase shares of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Grant paid to authority ASSETS Assets: Risk free interest rate Risk-free interest rate Risk-free interest rate (weighted average) Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Prepaid expenses and other current assets Document Fiscal Year Focus CASH FLOWS FROM INVESTING ACTIVITIES Accounts payable Exercise price Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Summary of Prepaid Expenses and Other Current Assets Proceeds from Stock Options Exercised Proceeds from the exercise of options Commitments and Contingencies Disclosure [Abstract] Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs Public offering sale of common stock, warrants, and prefunded warrants, offering costs Common stock and pre-funded warrants per share. Common Stock and Pre-Funded Warrants Per Share Common stock warrant Unrecognized Compensation Costs [Net Cash Provided by (Used in) Investing Activities] Net cash provided by investing activities Security 12b Title Related and Nonrelated Parties [Domain] Class of Warrant or Right [Line Items] Changes in operating assets and liabilities Additional Paid-In Capital Additional Paid-In Capital [Member] Trading Symbol Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, maximum Subsequent Event Type [Axis] Employee Related Employee related Employee-related Liabilities, Current, Total CASH FLOWS FROM FINANCING ACTIVITIES Expected term (in years) Expected Life Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Liabilities Equity Components [Axis] Equity Component [Domain] Summary of Significant Accounting Policies [Table] Summary of significant accounting policies. [Cumulative Earnings (Deficit)] Accumulated deficit Share Based Compensation Arrangement by Share Based Payment Award, Terms of Stock Options Share based compensation arrangement by share based payment award, terms of stock options. Stock options, term Other Assets [Abstract] Other current assts: Maximum [Member] Maximum Statistical Measurement [Axis] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average exercise price per Share, Exercised Prepaid Expense, Current Prepaid expenses Total prepaid expenses Common stock, par value $0.0001 per share; authorized 400,000,000 shares; issued and outstanding 24,275,500 as of March 31, 2026 and 9,314,130 as of December 31, 2025, respectively August two zero twenty four warrants. August Two Zero Twenty Four Warrants [Member] August 2024 Warrants [Member] Reclassification of Prior Year Presentation Expected Volatility Volatility Factor Rate Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Chief Medical Officer [Member] Entity Registrant Name Pre Funded Warrants Member Pre-Funded Warrants [Member] Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Other (expense) income, net Other expense, net Additional paid-in capital SUBSEQUENT EVENTS Subsequent Events [Accounts Payable and Accrued Liabilities, Current] Total Total accrued liabilities Significant Accounting Policies [Policy Text Block] Significant Accounting Policies. Significant Accounting Policies Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Entity Common Stock Shares Outstanding Concentration Risk, Credit Risk, Policy [Policy Text Block] Cash Concentration Risk Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period RSUs granted [Assets] Total assets Remaining contractual term Weighted average remaining contractual life Options exercisable CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Preferred Stock, No Par Value Preferred stock, par value Earnings Per Share, Diluted Net loss per share, diluted Earnings Per Share, Diluted, Total Schedule of Segment Reporting Information, by Segment [Table Text Block] Summary of Significant Expense and Asset Categories Title and Position [Domain] City Area Code Exercise Of Pre Funded Warrants Shares Exercise of pre-funded warrants, shares Exercise of pre-funded warrants, net Stock Option Award Granted Offering Price Award Date [Axis] Exercised Warrants, Exercised Net operating loss Net operating loss Operating Loss Carryforwards Net operating loss Net operating loss Net operating loss Award Date [Domain] Accumulated Deficit Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense, Total [Net Cash Provided by (Used in) Financing Activities] Net cash provided by financing activities Schedule of Warrants Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Public offering sale of common stock, warrants and prefunded warrants, net of offering costs, amount. Public Offering Sale of Common Stock, Warrants and Prefunded Warrants, Net of Offering Costs, Amount Public offering sale of common stock, warrants and prefunded warrants, net of offering costs, amount Anti-dilutive Securities Entity Interactive Data Current CASH FLOWS FROM OPERATING ACTIVITIES Preferred Stock convertible into share of common stock Convertible Preferred Stock, Shares Issued upon Conversion 2022 Stock Incentive Plan Two Thousand Twenty Two Stock Incentive Plan Member Proceeds from issuance of warrants and pre-funded warrants, net of issuance costs Interest income Interest income Interest income Interest income Entity Tax Identification Number [Repayments of Notes Payable] Payments on short-term note Series A Stock Plan Schedule of outstanding stock options Schedule of Outstanding Stock Options Local Phone Number Prepaid Clinical Research Organizations Expenses Prepaid clinical research organizations expenses. Prepaid CRO expenses Grant paid to canadian authority SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue from Contract with Customer, Excluding Assessed Tax Product revenue Warrants, Weighted Average Exercise Price, Excercised Class of Stock [Domain] Entity Emerging Growth Company